BALCX
Price
$38.70
Change
+$0.06 (+0.16%)
Updated
Oct 6 closing price
Net Assets
265.73B
TSHIX
Price
$15.97
Change
+$0.02 (+0.13%)
Updated
Oct 6 closing price
Net Assets
830.41M
Interact to see
Advertisement

BALCX vs TSHIX

Header iconBALCX vs TSHIX Comparison
Open Charts BALCX vs TSHIXBanner chart's image
American Funds American Balanced C
Price$38.70
Change+$0.06 (+0.16%)
VolumeN/A
Net Assets265.73B
Transamerica Multi-Asset Income I
Price$15.97
Change+$0.02 (+0.13%)
VolumeN/A
Net Assets830.41M
BALCX vs TSHIX Comparison Chart in %
View a ticker or compare two or three
VS
BALCX vs. TSHIX commentary
Oct 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BALCX is a Buy and TSHIX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
BALCX has more cash in the bank: 266B vs. TSHIX (830M). TSHIX pays higher dividends than BALCX: TSHIX (3.46) vs BALCX (1.12). BALCX was incepted earlier than TSHIX: BALCX (25 years) vs TSHIX (12 years). BALCX (1.31) is less costly to investors than TSHIX (0.73). BALCX (44.00) and TSHIX (42.00) have comparable annual turnover. BALCX has a lower initial minimum investment than TSHIX: BALCX (250) vs TSHIX (1000000). TSHIX annual gain was more profitable for investors over the last year : 14.23 vs. BALCX (8.78). TSHIX return over 5 years is better than : 60.38 vs. BALCX (39.29).
BALCXTSHIXBALCX / TSHIX
Total Expense Ratio1.310.72182%
Annual Report Gross Expense Ratio1.310.73179%
Fund Existence25 years12 years-
Gain YTD14.07113.036108%
Front LoadN/AN/A-
Min. Initial Investment25010000000%
Min. Initial Investment IRAN/AN/A-
Net Assets266B830M32,048%
Annual Yield % from dividends1.123.4632%
Returns for 1 year8.7814.2362%
Returns for 3 years48.3948.8899%
Returns for 5 years39.2960.3865%
Returns for 10 years69.27117.0759%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
EMX5.310.34
+6.84%
EMX Royalty Corp
SMMT22.150.72
+3.36%
Summit Therapeutics
TUSK2.30N/A
N/A
Mammoth Energy Services
HURN150.20-0.12
-0.08%
Huron Consulting Group
APRE1.49-0.02
-1.00%
Aprea Therapeutics